Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy.

ABSTRACT: Human endogenous retroviruses (HERVs) represent 8% of the human genome. HERV products may represent tumor antigens relevant for cancer immunotherapy. We developed a bioinformatic approach to identify shared CD8⁺ T cell epitopes derived from cancer-associated HERVs in solid tumors. Six candidates among the most commonly shared HLA-A2 epitopes with evidence of translation were selected for immunological evaluation. In vitro priming assays confirmed the immunogenicity of these epitopes, which induced high-avidity CD8⁺ T cell clones. These T cells specifically recognize and kill HLA-A2⁺ tumor cells presenting HERV epitopes on HLA molecules, as demonstrated by mass spectrometry. Furthermore, epitope-specific CD8⁺ T cells were identified by dextramer s

SUBMITTER: Bonaventura P 

PROVIDER: S-EPMC8791462 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature